Evidence Synthesis
KREBSBIO experienced a standard shift in its financial performance.
Gross margin accelerated to , up from -35.73%. Marginal operating leverage accelerated to , up from -71.35%. Revenue growth year-over-year accelerated to .
Daily volume increased by 4.674 times. Close price decreased by 0.042 times.
By paying you agree to our Terms and Privacy Policy.